A new pilot program uses regulated prediction markets and independent data verification to establish public probabilities for ...

Most obesity drugs do not improve quality of life or heart health, according to a review published online July 8 in The BMJ.

Phase 1/2 DELIVER data demonstrated statistically significant dystrophin expression, functional improvements, and a favorable safety profile with z-rostudirsen.

Higher diagnostic accuracy reported for dementia experts vs primary care doctors before disclosure of test results, but not after.